Spots Global Cancer Trial Database for Open Registry Measuring Impact of Genomic Testing on Treatment of Prostate Cancer Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Open Registry Measuring Impact of Genomic Testing on Treatment of Prostate Cancer Patients
Official Title: An Open Registry to Measure the Impact of Adding Genomic Testing (Prolaris®) on the Treatment Decision Following Biopsy in Newly Diagnosed Prostate Cancer Patients
Study ID: NCT01954004
Conditions
Interventions
Study Description
Brief Summary: This registry is intended to evaluate the impact of genomic test results towards selecting a first-line therapy option for newly diagnosed localized prostate cancer patients.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
, Salt Lake City, Utah, United States
Contact Details
Name: Richard Wenstrup, MD
Affiliation: Myriad Genetic Laboratories, Inc.
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
